Why North America Region is Dominating the Billion Dollar Psychedelic Drugs Market
The UK s psychedelic drugs market is growing rapidly due to the increasing prevalence of depression and other mental illnesses worldwide, according to a report from Data Bridge. The growth is likely to attract major investments in the near future.
Source: prnewswire.comPublished on 2021-10-05
Related news
- The New Humanitarian | Is it possible to predict future forced displacement ?
- Greece Signs Agreement With Amazon For Innovation Space Hub
- Origin Launches Airbrush , A Universal Data Standard Aiming To Optimise Bond Issuance
- Diameter Health and Smile CDR Announce Partnership to Provide Best - of - Breed FHIR Solutions
- Food Safety : CMX and FDA - Challenge Winner Mojix Partner to Launch First Open Access Food Traceability Platform
- Trace Labs , the OriginTrail core team , receives support from the World Economic Forum to ensure safer buying of COVID - 19 protective equipment using blockchain
- Codat Announces Partnership with Intuit to Speed QuickBooks App Development And Catalyze New Wave of Open Finance
- The progress of Open Banking and road ahead
- RMS Launches New Climate Change Models
- Taking Ocean Vital Signs
- Why demand is strong for Canada 6 new immigration programs
- Corelight Secures $75 Million in Series D Funding Led by Energy Impact Partners
- Biotech Companies Driving Psychedelics Industry Forward with Key Research
- Book Review | The City is Not A Computer - Spacing National